Dmytro Fishman, Chief Science Officer and Founder at Better Medicine
's portfolio company Better Medicine
- co-founded by the University of Tartu Institute of Computer Science lecturer, has received a large grant from European Innovation Council’s Accelerator.
Thanks to cutting-edge research at the Institute of Computer Science, Better Medicine, a company that automates the analysis of cancer CT scans, has received a boost. Better Medicine was recently awarded with a €2.5 million grant from the European Innovation Council’s Accelerator.
, Lecturer in Artificial Intelligence at the Institute of Computer Science and co-founder of Better Medicine,
says that thanks to high-level research in applying artificial intelligence, a company was born that started looking for practical solutions to make life easier for doctors and patients. “At the Institute of Computer Science, we do world-class research that helps companies find and maintain their competitive advantage, and that is why companies should be more bold in investing in R&D,
” says Dmytro Fishman.
The collaboration between the Institute of Computer Science and Better Medicine has been mutually beneficial and has resulted in an innovative way to analyse CT scans. In particular, the AI-powered solution, unlike other methods in use, is able to detect the metastatic spread of cancer in different organs throughout the body and assess disease progression and response to treatment. Given that metastatic cancer is responsible for 90% of all cancer deaths, Better Medicine is transforming the diagnostic market by significantly reducing the time to diagnose metastases.
The European Innovation Council Accelerator has recently provided support to several Estonian health technology start-ups. Among others, Better Medicine received a €2.5 million grant.
“It is really hard to overstate the importance of this accomplishment for our company, but also for the entire field. I could not be happier. Years of research are being put into practice for the sake of doctors and patients. This is really the main reason why I became a scientist.
” added Dmytro Fishman.
Read more (in Estonian):
Eesti AI-ettevõte aitab tuvastada vähi levikut terves kehas ning hinnata haiguse progresseerumist ja ravivastust - Forte (delfi.ee)
**Photo credit: Accuray on Unsplash
/ Henry Narits